134 related articles for article (PubMed ID: 19457706)
1. Using YC-1 to overcome the radioresistance of hypoxic cancer cells.
Moon SY; Chang HW; Roh JL; Kim GC; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
Oral Oncol; 2009 Oct; 45(10):915-9. PubMed ID: 19457706
[TBL] [Abstract][Full Text] [Related]
2. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
3. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
4. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.
Oommen D; Prise KM
Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642
[TBL] [Abstract][Full Text] [Related]
5. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells].
Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109
[TBL] [Abstract][Full Text] [Related]
7. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
DeNiro M; Alsmadi O; Al-Mohanna F
Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
[TBL] [Abstract][Full Text] [Related]
8. YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells.
Harada T; Hirose K; Wada Y; Sato M; Ichise K; Aoki M; Kato T; Takeda K; Takai Y
J Radiat Res; 2020 Jul; 61(4):524-534. PubMed ID: 32367141
[TBL] [Abstract][Full Text] [Related]
9. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.
Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R
Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428
[TBL] [Abstract][Full Text] [Related]
10. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.
Harada H; Itasaka S; Zhu Y; Zeng L; Xie X; Morinibu A; Shinomiya K; Hiraoka M
Br J Cancer; 2009 Mar; 100(5):747-57. PubMed ID: 19223896
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer.
Ikezawa Y; Sakakibara-Konishi J; Mizugaki H; Oizumi S; Nishimura M
Int J Clin Oncol; 2017 Feb; 22(1):59-69. PubMed ID: 27553958
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.
Qi R; Jin W; Wang J; Yi Q; Yu M; Xu S; Jin W
Oncol Rep; 2014 May; 31(5):2399-406. PubMed ID: 24604140
[TBL] [Abstract][Full Text] [Related]
13. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
[TBL] [Abstract][Full Text] [Related]
17. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases.
Yeo EJ; Ryu JH; Chun YS; Cho YS; Jang IJ; Cho H; Kim J; Kim MS; Park JW
Cancer Res; 2006 Jun; 66(12):6345-52. PubMed ID: 16778212
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW
Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]